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The IgM Anti-Desmoglein 1 Response Distinguishes
Brazilian Pemphigus Foliaceus (Fogo Selvagem)
from Other Forms of Pemphigus
Luis A. Diaz1, Phillip S. Prisayanh1, David A. Dasher1, Ning Li1, Flor Evangelista1, Valeria Aoki2,
Gunter Hans-Filho3, Vandir dos Santos4, Bahjat F. Qaqish5 and Evandro A. Rivitti2 for the Cooperative
Group on Fogo Selvagem Research
Fogo selvagem (FS) and pemphigus foliaceus (PF) possess pathogenic IgG anti-desmoglein 1-(Dsg1)
autoantibodies. Although PF occurs sporadically, FS is endemic in Limao Verde (LV), Brazil (3.4% prevalence).
IgM anti-Dsg1 were detected in 58% FS LV patients (n¼ 31), 19% of FS patients from Hospital-Campo Grande
(n¼ 57), 19% from Hospital-Goiania (n¼ 42), 12% from Hospital-Sao Paulo (n¼ 56), 10% of PF patients from
United States (n¼ 20), and 0% of PF patients from Japan (n¼ 20). Pemphigus vulgaris (n¼ 40, USA and Japan),
bullous pemphigoid (n¼ 40, USA), and healthy donors (n¼ 55, USA) showed negligible percentages of positive
sera. High percentages of positive IgM anti-Dsg1 were found in healthy donors from four rural Amerindian
populations (42% of 243) as compared with urban donors (14% of 81; Po0.001). More than 50% of healthy
donors from LV (n¼ 99, age 5–20 years) possess IgM anti-Dsg1 across ages, whereas IgG-anti-Dsg1 was detected
in 2.9% (age 5–10 years), 7.3% (age 11–15 years), and 29% of donors above age 16. IgM anti-Dsg1 epitopes are
Ca2þ and carbohydrate-independent. We propose that IgM anti-Dsg1 are common in FS patients in their native
environment and uncommon in other pemphigus phenotypes and in FS patients who migrate to urban
hospitals. Recurrent environmental antigenic exposure may lead to IgM and IgG responses that trigger FS.
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INTRODUCTION
Fogo selvagem (FS) and pemphigus foliaceus (PF) share
clinical and histological features, and are characterized
serologically by pathogenic IgG4 autoantibodies against
desmoglein 1 (Dsg1) (Rock et al., 1989; Stanley et al.,
1986; Diaz et al., 1989a). PF occurs sporadically in North
America, Europe, and Asia, whereas FS is endemic among
poor laborers of all races and both sexes living in certain
endemic regions of Brazil (Diaz et al., 1989b).
The Amerindian reservation of Limao Verde (LV), located
in the state of Mato Grosso do Sul, Brazil, is the home of
B1,200 members of the Terena tribe of Amerindians, and is
an active focus of FS, exhibiting a 3.4% prevalence of disease
(Figure 1) (Hans-Filho et al., 1996). For the past 12 years, we
have periodically collected clinical and serological data from
FS patients as well as clinically normal individuals residing in
and around this settlement. We have found that the
autoantibody response against Dsg1 in healthy individuals
from LV and neighboring communities is common, and
directly related to proximity to this reservation (Warren et al.,
2000; Hilario-Vargas et al., 2006). Over the course of this
investigation, we have also observed the clinical and serological
conversion from normal-to-disease state in 10 individuals
(Warren et al., 2000; Li et al., 2003). These conversions were
marked by a transition from IgG1 autoantibodies targeting the
EC5 domain of Dsg1 during the preclinical stage to a
predominantly IgG4-mediated autoantibody response against
the Dsg1 EC1-2 domains with the onset of clinically active
disease (Li et al., 2003; Warren et al., 2003).
Several studies support the concept that the autoimmune
response in FS is triggered by an exposure to, an as yet
unknown, environmental antigen(s). Previous epidemiologi-
cal studies have shown that the incidence of FS tends to
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decrease as living conditions of endemic populations improve,
as observed in the states of Sao Paulo and Parana over the past
four decades (Diaz et al., 1989b; Empinotti et al., 2006).
Additional seroepidemiological studies suggest that exposure
to blood feeding arthropods such as simuliids, bed bugs, and
reduvid bugs, as well as poor housing are potential risk factors
of FS (Aoki et al., 2004). Furthermore, the sera of patients with
leishmaniasis, onchocerciasis, and Chagas disease contain
significant titers of anti-Dsg1 autoantibodies specific for the
EC5 domain, suggesting that arthropod antigens may cross-
react with epidermal Dsg1, thus triggering autoantibody
formation in individuals exposed to these arthropods (Diaz
et al., 2004). It should be stressed that attempts to isolate or
directly associate FS to bacterial and viral infections have been
unsuccessful to date (Diaz et al., 1989a, b).
In an effort to detect unique serological markers that may
distinguish FS from PF, sera from patients with FS and PF as
well as clinically normal individuals from Brazil, United
States, and Japan were tested for the presence of IgM anti-
Dsg1 autoantibodies using ELISA. These studies were
facilitated by the availability of serum samples from Brazilian
hospitals and highly endemic regions of FS in Brazil (depicted
in Figure 1). Findings suggest that the IgM anti-Dsg1
autoantibody response is a distinct marker of antigenic
exposure within an endemic area, and is prevalent in FS
patients as well as clinically normal individuals living in LV
and its neighboring rural regions. It is hypothesized that the
IgM anti-Dsg1 autoantibody response in humans exposed to
an environmental antigen(s) may represent the earliest event
in the sensitization process that leads to FS.
RESULTS
Anti-Dsg1 IgM and IgG autoantibodies in FS and non-endemic
PF
We first evaluated the IgM and IgG anti-Dsg1 response in FS
and PF patients segregated in groups. The first group included
sera from FS patients living in their native environment, LV.
Other groups included sera from FS patients admitted in three
Brazilian hospitals located in the cities of Campo Grande
(CG, state of Mato Grosso do Sul), Goiania (GO, state of
Goias), and Sao Paulo (SP, state of Sao Paulo). The remaining
two groups comprise PF patients from the US (PF-USA) and
Japan (PF-Japan). The percentages of individuals showing
positive IgM (cutoff above 50) and IgG (cutoff above 10) anti-
Dsg1 index values in each of these groups are shown in
Figure 2, while Figure S1 provides additional information
about the distribution of index values in these groups. The
specificity of the IgM reactivity of the FS/PF sera with Dsg1
The endemic regions of Fogo Selvagem in Brazil
Mato Grosso do Sul
Brazil
Brasilia
85 km 135 km
Limao Verde
Figure 1. Map of South America and Brazil depicting sites of donor serum collection. These sites are located in known endemic regions of FS. Specialized
hospitals in the cities of Sao Paulo (state of Sao Paulo), Goiania (state of Goias), Brasilia (capital of Brazil), and Campo Grande (state of Mato Grosso do Sul)
are referral centers for FS patients from the central planes of Brazil. LV, with a population of B1,200 individuals is an active focus of FS (3.4% prevalence)
and is located in the state of Mato Grosso do Sul. The Amerindian reservations of Bananal, Ipegue, and Agua Branca are located 85 km west of LV and
are inhabited by the same Terena tribes who live in LV. The Bananal and Ipegue reservations have an estimated population of 5,000 individuals. Aquidauana
city with a population of 40,000 inhabitants is located 25 km southwest of LV. Campo Grande (state capital) has a population of 300,000 inhabitants and
is located 135 km east of Aquidauana. The city of Sao Paulo with a population of 12 million is located approximately 1000 km east of Campo Grande.
Goiania city has a population of 400,000 and is located 900 km northeast of Campo Grande.
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was also investigated by testing positive IgM anti-Dsg1 sera
(n¼8) with an unrelated epidermal antigen recognized by
bullous pemphigoid (BP) sera by ELISA, that is the BP180
antigen (Liu and Diaz, 2001). We found no significant IgM
reactivity against this antigen in these sera. This finding is in
agreement with early reports from our group where we found
no IgG reactivity of FS sera with either BP180 antigen
(Warren et al., 2000) or antinuclear antibodies (Squiquera
et al., 1988). Additionally, the Dsg1 ELISA for IgA anti-Dsg1
autoantibodies in 15 sera tested, including the normal
human USA sera (n¼ 7), PF serum (n¼ 1), FS sera (n¼ 5),
and healthy Amerindian donors from Brazil (n¼2), showed
negative results. Finally, the results obtained by two
independent investigators testing for IgM anti-Dsg1 auto-
antibodies in a set of 48 positive and negative coded sera
demonstrated a perfect linear relationship (correlation coeffi-
cient 0.977, Po0.001).
As shown in Figure 2 (white columns) and Figure S1A in
LV, a highly endemic focus of FS, 58% of 31 cases were
positive for IgM anti-Dsg1 autoantibodies. We found no
correlation of IgM anti-Dsg1 autoantibodies with age or sex
of 31 FS patients. Of 10 FS patients ranging in age from 15 to
25 (four females and six males), sera from six demonstrated
IgM anti-Dsg1 autoantibodies. Sera from 10 of 17 patients
age 26–50 years (10 females and 7 males) had IgM anti-Dsg1
autoantibodies. Finally, positive IgM serology was detected in
2 of 4 FS patients age 60–80 years. Of the 31 FS patients, 8
were in clinical remission and 3 of these patients showed
positive IgM anti-Dsg1 autoantibodies. Fifteen of 23 FS
patients (65%) with active clinical disease showed positive
IgM anti-Dsg1 serology. In contrast, the percentage of
positive IgM anti-Dsg1 sera was lower in patients staying in
urban hospitals away from their native environment. Only
19% of 57 patients admitted to Hospital-CG, 19% of 42 cases
from Hospital-GO, and 12% of 56 patients from Hospital-SP
were positive. Similarly, in only 10% of 20 PF-USA patients
and none of 20 PF-Japan donors were positive. Significant
heterogeneity exists in the prevalence of IgM antibodies
between the six different settings (P40.001). However, most
of the differences were between LV, the hospital-based group
(CG, GO, and SP), and the PF group (USA and Japan). The
differences among the three hospital-based groups were
small (P¼ 0.56), as was the difference between PF-USA and
PF-Japan (P¼ 0.15).
The serum samples from the six groups were also tested by
ELISA for IgG anti-Dsg1 autoantibodies. As shown in Figure 2,
dark columns, and Figure S1B, IgG autoantibodies were
detected in 61% of FS patients from LV, 75% from Hospital-
CG, 90% from Hospital-GO, 91% from Hospital-SP, 70%
of 20 PF-USA, and 100% of 20 PF cases from Japan. These
results are consistent with what is known in the literature, that
is IgG anti-Dsg1 autoantibodies are diagnostic markers of FS
and rough indicators of disease activity (Rock et al., 1983;
Stanley et al., 1986; Diaz et al., 1989a).
To test if binding of IgG anti-Dsg1 autoantibodies would
interfere with the binding of IgM anti-Dsg1 autoantibodies,
five representative high-titer FS sera were tested by ELISA
double dilutions (1:100, 1:200, 1:400, and 1:800), and
estimated IgM and IgG index values were obtained. No
changes in the index values of IgM and IgG autoantibodies
were observed across all dilutions. Additionally, microtiter
wells coated with recombinant Dgs1 were preincubated with
a high-titer IgG anti-Dsg1 serum before testing a set of IgM
anti-Dsg1-positive sera (n¼ 4). No changes in IgM index
values in these sera were observed.
Anti-Dsg1 IgM and IgG autoantibodies in pemphigus vulgaris
and BP
To investigate further the disease specificity of the anti-Dsg1
response, we tested the sera of patients with other cutaneous
autoimmune diseases. One group comprises patients with
pemphigus vulgaris (PV), a potentially lethal organ-specific
autoimmune disease characterized by mucosal and/or skin
erosions and blisters and autoantibodies against Dsg3
(Amagai et al., 1991). One clinical variant of PV is
characterized by mucosal lesions (mucosal pemphigus
vulgaris (mPV)) and the other exhibits mucocutaneous lesions
(mucocutaneous pemphigus vulgaris (mcPV)) (Ding et al.,
1997; Amagai et al., 1999). Whereas IgM anti-Dsg1
autoantibodies have never been reported in the sera of PV
patients, IgG anti-Dsg1 autoantibodies are commonly de-
tected in mcPV (Ding et al., 1999). In this study we found IgM
anti-Dsg1 autoantibodies in 0% of 10 mPV and 0% of 10
mcPV patients from United States and in 5% of 20 mPV and
5% of 20 mcPV from Japanese patients. IgG anti-Dsg1
autoantibodies were detected in 50% of 10 mcPV sera from
United States and in 75% of 20 mcPV patients from Japan.
These IgG anti-Dsg1 autoantibodies were absent in the sera
of mPV from United States (n¼10) and Japanese (n¼20)
patients. We also studied the sera of another organ-specific
autoimmune skin disease, BP, which is characterized by
subepidermal blisters and autoantibodies against two hemi-
desmosomal antigens, that is BP230 and BP180 (Liu and
Diaz, 2001). We found IgM anti-Dsg1 autoantibodies in 5%
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Figure 2. IgM and IgG anti-Dsg1 reactivity of sera from patients with FS
and PF. White columns show the percentages of donors from each group
(LV, CG, GO, SP, PF-USA and PF-Japan) possessing positive values of IgM
anti-Dsg1 autoantibodies and dark columns show the percentages of
donors possessing positive values of IgG anti-Dsg1 autoantibodies. The
number of donors in each group is included under each site.
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of 40 BP patients from United States. IgG anti-Dsg1
autoantibodies were detected in 10% of these cases. These
results further demonstrate the restricted IgM anti-Dsg1
response in FS patients living in LV.
Anti-Dsg1 IgM and IgG autoantibodies in clinically healthy
individuals from rural and urban populations
To further investigate the prevalence of IgM and IgG anti-
Dsg1 autoantibodies in populations prone to develop FS, we
tested the sera of healthy Amerindians living in rural endemic
areas of FS in Brazil. These results were compared with the
sera from normal individuals living in a semi rural city
(Aquidauana) and other Brazilian cities distant from LV, the
endemic focus of FS. As shown in Figure 3a (white columns)
the sera of donors from rural areas (LV, Bananal, Ipegue, and
Agua Branca) exhibit higher prevalence of IgM anti-Dsg1
autoantibodies than those donors from urban communities
(Aquidauana, Campo Grande, and Sao Paulo) and United
States. Figure S2A provides additional information about
the distribution of index values. The heterogeneity in the
proportions of positive IgM anti-Dsg1 sera among the four
urban donors (P¼ 0.04) was more marked than among the
rural individuals (P¼0.09). The prevalence of IgM anti-Dsg1
autoantibodies were 42% in the rural group and 14% in the
urban group (Po0.001).
The prevalence of positive IgG anti-Dsg1 sera was also
higher among healthy Amerindians from rural areas of LV,
Bananal, Ipegue, and Agua Branca as compared with urban
donors of Aquidauana, Campo Grande, Sao Paulo, and
United States (Figure 3a, dark columns, and Figure S2B).
These results confirm that IgM and IgG anti-Dsg1 autoanti-
bodies are also present in the sera of healthy individuals
living in rural areas of Brazil, where FS is endemic (Warren
et al., 2000; Hilario-Vargas et al., 2006). Additionally, we
have shown that these rural populations, settled in endemic
areas of FS, possess IgG anti-Dsg3 autoantibodies (markers of
PV) and in a few of these individuals an ‘‘endemic’’ form of
mcPV may develop (Rocha-Alvarez et al., 2007).
The IgM and IgG anti-Dsg1 response from neonatal, childhood
to early adulthood
We also tested the IgM and IgG anti-Dsg1 response from
childhood to adulthood in a large group of normal donors age
5–20 years (n¼99) from LV. As shown in Figure 3b, 53% of
individuals of the first cohort (age 5–10 years, n¼34), 51% of
the second (age 11–15 years, n¼41), and 62.5% of the third
cohort (age 16–20 years, n¼25) exhibited positive IgM anti-
Dsg1 results. Of interest, the IgG anti-Dsg1 response was
detected in 2.9% of donors of the first cohort, 7.3% of the
second cohort, and 29% of the third cohort. Figure S3 shows
index values of IgM and IgG anti-Dsg1 autoantibodies plotted
against age. The sample size in these analyses is 98. This
analysis excluded one IgG index value above 80 from a 19-
year-old subject who was later diagnosed with FS. Linear
regression models were used in the analysis of trends in IgM
and IgG levels with age. There was no significant trend in the
IgM index values (P¼0.76), but the trend for IgG index
values was significant. The mean IgG index is estimated to
increase by 0.45 units with each year of age, 95% confidence
interval (0.032, 0.87), P¼0.037.
Sera from eight pairs of mothers with FS and their neonates
were tested for IgG and IgM anti-Dsg1 autoantibodies by
ELISA (Rocha-Alvarez et al., 1992). We found that mothers’
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Figure 3. IgM and IgG anti-Dsg1 reactivity of sera from healthy control
individuals. (a) Prevalence of IgM and IgG anti-Dsg1 autoantibodies in sera
from donors of rural and urban sites. White columns show the percentages of
donors of each group possessing positive values of IgM anti-Dsg1
autoantibodies. Rural donors: Limao Verde, Bananal, Ipegue, and Agua
Branca. Urban donors: Aquidauana, Campo Grande, Sao Paulo, and United
States. The dark columns show the percentages of donors possessing IgG anti-
Dsg1 autoantibodies (same subjects). The number of donors in each site is
provided at the bottom of each site. (b) IgM and IgG anti-Dsg1 reactivity
of sera from healthy donors age 5–20 years old sorted out in three age
groups (age 5–10, 11–15, and 16–20 years old). The percentages of donors
possessing positive IgM anti-Dsg1 values (white columns) and the percentage
of donors of each cohort possessing IgG anti-Dsg1 autoantibodies (dark
columns). One donor who showed the highest index value for IgG anti-Dsg1
in cohort-3 developed FS during the course of this study. The number
of donors is provided at the bottom of each cohort.
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sera showed high index values of IgG and IgM anti-Dsg1
autoantibodies. The neonates, however, showed negative
index values of IgM autoantibodies (data not shown).
IgM anti-Dsg1 autoantibodies bind calcium and
N-glycosylation-independent epitopes
To test the effects of calcium and N-glycosylation on IgM
binding to Dsg1, we selected a set of FS sera and a set of
healthy individuals, known to have IgM anti-Dsg1 auto-
antibodies, to investigate whether these antibodies recognize
Ca2þ -dependent epitopes or carbohydrate epitopes on Dsg1.
Deglycosylated Dsg1 was prepared in the baculovirus system
by incorporating tunicamycin in the expression step (Amagai
et al., 1995). The deglycosylated Dsg1 was further purified by
concanavalin-A agarose affinity chromatography by collect-
ing the unbound fraction. Deglycosylated Dsg1 showed the
respective reduction on molecular weight by SDS–PAGE (data
not shown). The glycosylated Dsg1 was tested by ELISA in the
presence of Ca2þ (routinely added to Tris-buffered saline
used in ELISA procedures) or in the absence of Ca2þ (5mM
EDTA added to Tris-buffered saline). The results show that
IgM anti-Dsg1 autoantibodies continue to bind Dsg1 in the
absence of Ca2þ (Figure 4a); in fact the values were higher
(P¼0.0042). Similarly, IgM anti-Dsg1 autoantibodies from FS
patients and healthy individuals continue to bind deglycol-
sylated Dsg1 (Figure 4b). On the contrary, EDTA completely
abrogates the IgG anti-Dsg1 autoantibodies reactivity with
Dsg1 (data not shown). These results demonstrate that IgM
anti-Dsg1 and the IgG anti-Dsg1 autoantibody systems
present in the sera of FS patients and normal individuals are
distinct.
IgM anti-Dsg1-positive sera do not stain the epidermis by
indirect immunofluorescence, but immunoprecipitate Dsg1
Twenty sera from the following individuals were selected: (a)
FS (n¼3) and PF (n¼ 1), and (b) healthy donors (n¼16)
exhibiting high index values of IgM anti-Dsg1 autoantibodies
by ELISA. Ten normal donors from Amerindian reservations
had low index values for IgG anti-Dsg1, and six had high
index values of IgG anti-Dsg1. The four sera from patients
comprising FS and PF had high index values of IgG anti-Dsg1
by ELISA. All 20 serum samples produced negative indirect
immunofluorescence (IF) staining of the intercellular spaces
of human skin and monkey esophagus for IgM autoantibo-
dies. The sera of the four FS and PF patients stained the
human skin and monkey esophagus epithelial cell surfaces,
producing the classic pemphigus pattern using FITC-labeled
anti-human IgG conjugate.
The sera from four patients (three FS and one PF) who
possessed IgM anti-Dsg1 autoantibodies by ELISA also
recognized Dsg1 by immunoprecipitation/immunoblot ana-
lysis as shown in Figure 5 (lanes 4, 7, 9, and 10). The sera of
three normal donors from Amerindian reservations (lanes 5,
6, and 8) exhibiting IgM autoantibodies by ELISA also bind
Dsg1 by IP. The same Dsg1 peptide was bound by IgG
autoantibodies from a patient with FS (lane 2).
DISCUSSION
Immunization of naive individuals to a particular antigen
usually triggers a primary immune response characterized by
low-affinity IgM antibodies. Re-exposure to the same antigen
subsequently precipitates a sustained secondary response
characterized by high-affinity IgG antibodies (Abbas and
Lichtman, 2005). In humans, detection of antigen-specific
IgM antibodies in sera may be an indicator of a recent
infection or re-infection with viral diseases such as rubella
(Hamkar et al., 2005), infectious mononucleosis (Obel et al.,
1996), or hepatitis B (Chu, 2006); bacterial infections such as
Lyme disease (Cermakova et al., 2005); or parasitosis such as
toxoplasmosis (Montoya, 2002; Reis et al., 2006). In FS,
however, the etiology is obscure and there is no experimental
or clinical evidence that the disease may be linked to an
infectious or parasitic disease (Diaz et al., 1989a, b; Aoki
et al., 2004). It is also known that certain number of healthy,
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unimmunized individuals possess IgM antibodies to toxins,
bacteria, and erythrocytes that comprise a population of
polyreactive low-affinity natural antibodies (Manson et al.,
2005). These natural polyreactive IgM antibodies represent
the first barrier against infection, eliminating bacteria by
complement activation, thus bridging innate to adaptive
immunity (Manson et al., 2005). Many of these IgM natural
antibodies recognize single or multiple self-antigens, and
have been detected from early childhood throughout life
(Mouthon et al., 1996).
The IgM anti-Dsg1 autoimmune response observed in FS
patients living in their native environment is distinctive, and
represents a novel finding. The presence of IgM anti-Dsg1
autoantibodies in the sera of these patients was unrelated to
the age, sex, or the clinical stage of the disease. It remains
unknown if IgM, and pathogenic IgG and non-pathogenic
IgG anti-Dsg1 autoantibodies may segregate according to
the HLA of the individuals. A relatively high prevalence of
IgM anti-Dsg1 autoantibodies was found in sera from both
FS patients and clinically normal donors residing in
rural settings in or near an endemic area. Patients with PF,
other autoimmune bullous diseases, as well as healthy
individuals from more urban settings did not demonstrate
a significant IgM anti-Dsg1 response. Interestingly, the
percentage of positive IgM anti-Dsg1 is low in FS patients,
who temporarily resided in urban hospitals. It is likely
that serum concentrations of IgM anti-Dsg1 autoanti-
bodies from FS patients referred to metropolitan hospitals,
away from their native environment, decrease due to the
elimination of the environmental antigenic stimuli. We are
prospectively evaluating FS patients who migrate out of their
native environment to an urban hospital to test this
hypothesis. We are also studying healthy Amerindians from
LV or neighboring reservations, who have IgM anti-Dsg1
autoantibodies and migrate to urban centers away from their
reservation, and non-Amerindian healthy new arrivals to
these reservations. These studies may clarify the relationship
of IgM anti-Dsg1 autoantibodies and exposure to endemic
areas of FS. It is clear, however, that the humoral IgG and IgM
autoantibody response in inhabitants of rural endemic
regions of FS suggests strongly an environmental antigenic
exposure, especially in LV, the active focus of the disease.
Moreover, the IgM anti-Dsg1 response appears to distinguish
FS patients living in their native environment from the non-
endemic form of PF and other forms of pemphigus seen in
other parts of the world.
It is well documented that pathogenic IgG anti-Dsg1
autoantibodies from PF and FS patients recognize conforma-
tional and Ca2þ -dependent epitopes on Dsg1 (Olague-Alcala
and Diaz, 1993; Amagai et al., 1995). We and others have
also reported that IgG anti-Dsg1 antibodies bind peptide
epitopes rather than carbohydrate moieties on the ectodo-
main of Dsg1 (Olague-Alcala and Diaz, 1993; Amagai et al.,
1995). In this study, we found that binding of IgM
autoantibodies to Dsg1 is both calcium and N-glycosylation
independent, suggesting that the epitopes recognized by IgM
anti-Dsg1 autoantibodies are different from those bound by
pathogenic IgG anti-Dsg1. These differences were also shown
by ELISA inhibition studies, which showed that IgG anti-Dsg1
autoantibodies do not impair the binding of IgM anti-Dsg1
autoantibodies. Another interesting finding in this study is
that IgM anti-Dsg1 reactivity was detected in healthy
individuals as early as age 5. The cord sera of eight neonates
did not contain IgM anti-Dsg1 autoantibodies but over 50%
of sera from healthy donors between age of 5 and 20 from LV
possessed IgM anti-Dsg1 autoantibodies. It is feasible that the
‘‘time 0’’ of the immunization process is the neonatal period
and the production of IgM anti-Dsg1 begins gradually
between this ‘‘time 0’’ and at the age of 5. There was no
significant trend in IgM anti-Dsg1 autoantibody with age.
However, the prevalence of IgG anti-Dsg1 autoantibodies
gradually increased with age of the donors (Figure 3b).
Notably, since the completion of the serological analysis for
this study, one 19-year-old donor (IgG index value480) has
since developed clinically active disease.
In view of these findings, we propose that the IgM anti-
Dsg1 autoantibody response represents the earliest event in
the sensitization process in individuals living in these rural
areas of Brazil. This event is followed by a gradual IgG
response leading to FS. It is likely that the IgM response in
individuals living in LV and other Amerindian reservations of
the region arises from recurrent and persistent exposure to a
putative environmental cross-reactive antigen(s) harbored in
these regions. The exposure seems to occur in early child-
hood and continues throughout life, if the individuals remain
in these regions. The resulting, likely low affinity IgM anti-
Dsg1 autoantibodies, would be detected by highly sensitive
ELISA assays but not by routine indirect IF studies. To further
explore the reactivity with epithelial tissues by indirect IF, we
selected a group of 20 sera from FS and PF patients, as well as
healthy controls possessing IgM anti-Dsg1 autoantibodies.
We found that all the 20 samples of sera did not bind the
1 2 3 4 5 6 7 8 9 10
Figure 5. IgM immunoprecipitation of recombinant Dsg1.
Immunoprecipitation of recombinant Dsg1 by IgM (lanes 3–10) and IgG (lane
2) from the sera of FS patients (lanes 2, 7, 9, and 10), a PF patient (lane 4), a
US normal donor (lane 3), and healthy donors from rural Brazilian
Amerindian reservations (lanes 5, 6, and 8).All sera were tested
at a 1:50 dilution, except the FS serum (lane 2) used to test for IgG anti-Dsg1
that was diluted at 1:200. Lane 1 is a molecular weight standard (66 kDa).
It is clear that IgG (lane 2) and IgM autoantibodies recognize Dsg1
(lanes 4–10). Normal human serum (lane 3) was negative.
672 Journal of Investigative Dermatology (2008), Volume 128
LA Diaz et al.
IgM Anti-Desmoglein Autoantibodies in Pemphigus
epidermal cell surfaces by indirect IF. On the contrary, the
sera of patients produced typical pemphigus IgG staining in
these tissues. As shown in Figure 5, these IgM-positive sera
bind Dsg1 by IP/IB techniques. Clinical disease may occur
only in a small fraction of genetically predisposed individuals
where the humoral immune response is switched from an
IgM response to the production of pathogenic IgG anti-Dsg1
autoantibodies. Importantly, FS is common among poor
outdoor young workers of both sexes and all races sharing the
HLA DRB1*0404, DRB1*1402, or DRB1*1406 alleles (RR:
14) (Diaz et al., 1989a, b; Moraes et al., 1997).
The role of IgM autoantibodies in autoimmunity has
recently become an area of great interest. Natural IgM
autoantibodies against self-antigens have been reported in
autoimmune diseases such as lupus erythematosus (Forger
et al., 2004; Ferreira et al., 2005; Li et al., 2005), autoimmune
hemolytic anemia (Stahl and Sibrowski, 2005), and auto-
immune thrombocytopenia (Stahl et al., 2005). It is hypothe-
sized that polyreactive IgM (Li et al., 2005) or the IgG/IgM
ratio of anti-dsDNA antibodies in systemic lupus erythema-
tosus may modulate the disease and prognosis, especially in
patients with nephritis (Forger et al., 2004). Experimentally,
passive transfer of monoclonal IgM anti-dsDNA autoantibo-
dies blocks inflammatory organ damage in lupus-prone mice
(NZB  NZW) F1 (Werwitzke et al., 2005). Others have
proposed that anti-Ro IgM autoantibodies in lupus may
represent part of the natural IgM repertoire that leads to the
production of pathogenic IgG autoantibodies by epitope
spreading in genetically predisposed individuals (Ferreira
et al., 2005). The potential clinical and pathological
significance of the IgM autoantibody response in the setting
of FS is an area of ongoing investigation.
Several important issues remain to be addressed in future
studies, such as the nature of the sensitizing environmental
antigen(s), whether it is T-dependent or T-independent, and the
role of self-Dsg1 in the production of these antibodies.
Furthermore, identification of the Dsg1 epitopes recognized
by IgM and IgG autoantibodies during the transition of the
disease from preclinical to clinical stages will also be relevant.
In conclusion, our studies suggest that IgM anti-Dsg1 auto-
antibodies are distinct markers of FS and may represent
excellent probes to test environmental antigens linked to FS.
FS is a fascinating model of a human organ-specific auto-
immune disease, mediated by pathogenic IgG autoantibodies,
where the immune response is linked to an environmental
etiology. Elucidating the etiology of FS may provide insight into
the pathogenesis of other human autoimmune diseases.
MATERIALS AND METHODS
Sources of sera from United States and Japan
The following groups of patients were tested: PF (n¼ 20), mPV
(n¼ 10), mcPV (n¼ 10), BP (n¼ 40), and normal human sera
(n¼ 55) from North Carolina, USA. Most of these patients were
receiving steroid or other immunosuppressive therapy at the time of
serum collection. Many were in complete or partial clinical
remission. Well-characterized sera from Japanese patients with
mPV (n¼ 20), mcPV (n¼ 20), and PF (n¼ 20) were obtained from
Professor M. Amagai from Keio University in Tokyo.
Sources of sera from Brazilian patients and controls
Sera from FS patients were obtained from the LV reservation, state of
Mato Grosso do Sul, Brazil (n¼ 31). Twenty-three patients were on
steroid therapy, and were in partial clinical remission at the time of
collection. The remaining eight patients were asymptomatic. FS sera
were also obtained from patients, most with extensive clinical
disease, admitted to the following Brazilian hospitals: Hospital das
Clinicas, Sao Paulo (Hospital-SP; n¼ 56), Hospital de Doenc¸as
Tropicaes, Goiania (Hospital-GO; n¼ 42), and Hospital Adventista
do Penfigo, Campo Grande (Hospital-CG; n¼ 57). Normal human
sera were obtained from donors residing in four Amerindian
reservations: LV (n¼ 103), Bananal (n¼ 58), Ipegue (n¼ 52), and
Agua Branca (n¼ 30), all inhabited by Terena Amerindians settled in
the state of Mato Grosso do Sul. Normal donors were also obtained
from three urban Brazilian cities: Aquidauana, Mato Grosso do Sul
(n¼ 27), Campo Grande (n¼ 27), and Sao Paulo (n¼ 27). Figure 1
shows the locations of relevant Brazilian cities and Amerindian
reservations.
Additional sources of sera
Additional sera were obtained from 99 young healthy donors, age
5–20 years, living in LV (34, age 5–10; 41, age 11–15; and 24, 16 and
older). Studies carried out in this investigation were approved by the
Institutional Review Boards of the University of North Carolina and
the University of Sao Paulo, Brazil. The study was conducted
according to the Declaration of Helsinki Principles. Participants gave
their written informed consent. Also available to this investigation
were eight sets of neonate/mother sera kept frozen since 1990
(Rocha-Alvarez et al., 1992). These sera were part of a study
evaluating the correlation of pemphigus autoantibodies in cord and
mother’s sera.
Production of baculovirus-expressed Dsg-1 (glycosylated and
deglycosylated)
The ectodomain of Dsg-1 with a C-terminal His tag was produced in
High FiveTM insect cells by infection with the recombinant
baculovirus stock of Dsg-1 (Ding et al., 1999; Li et al., 2003). To
generate the deglycosylated Dsg1, tunicamycin (Sigma, St Louis,
MO) was added to the culture medium (0.5 mgml1) at the time of
infection. The tunicamycin-treated (deglycosylated) and untreated
(glycosylated) recombinant Dsg1 were purified by nickel affinity
chromatography as described (Ding et al., 1999; Li et al., 2003) and
used for ELISA assay.
Anti-Dsg1 IgM and anti-Dsg1 IgA autoantibodies by IgG ELISA
assays
ELISA plates were coated with 200 ng per well of purified Dsg1 at
41C overnight. After washing with Tris-buffered saline containing
3.7mM Ca2þ and 0.05% Tween-20 (Tris-buffered saline/Ca2þ /
Tween-20), the plate was blocked with 1% BSA in Tris-buffered
saline/Ca2þ /Tween-20 at room temperature for 1 hour. The plate
was then incubated with duplicate 1:100 dilutions of serum samples
for 1 hour at room temperature. Following wash, the plate was
incubated with a 1:1000 dilution of horseradish peroxidase-labeled
mouse anti-human IgM or with 1:2000 dilution of horseradish
peroxidase-conjugated mouse anti-human IgG (Zymed, San Fran-
cisco, CA) (Warren et al., 2000, 2003). The assays produced a linear
reaction in the range of 6.25–800 ng of purified IgM or IgG. Similar
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procedures were followed to set the Dsg1 IgA ELISA, using Dsg1
immobilized on Ni-coated microtiter plates and monoclonal anti-
IgA antibodies (Zymed). A positive serum from a patient with IgA
pemphigus (showing a titer of IgA anti-epidermal cell surface
autoantibodies of 1:640 by indirect IF) was used as a positive
control. Positive, negative, and test sera were tested at a 1:100
dilution. Since the IgA pemphigus serum used as a positive control
exhibited marginal optical density (OD) readings at 490 nm above
background, it was not possible to determine reliable index values,
hence OD490 values were used to evaluate the reactivity of test sera.
A single FS serum from an LV patient who produced consistent and
reproducible positive index values for IgM anti-Dsg1 autoantibodies
was selected as a positive control throughout. Similarly a normal
human serum from USA was used as a negative control. Results were
expressed as index value units as reported by Amagai et al. (1999).
The index value was defined in terms of OD as follows:
index value ¼ ðtest sample ODÞ  ðnegative control ODÞðpositive control ODÞ  ðnegative control ODÞ100
The cutoffs for positive IgM and IgG values were determined by
testing 31 FS patients from LV (for IgM), 20 PF patients from Japan
(for IgG), and 50 normal human sera from United States. The index
values of IgM anti-Dsg1 produced by FS sera and normal human sera
were utilized to plot a receiver operator characteristic curve (see
Figure S4). We determined that index values of IgM anti-Dsg1
autoantibodies above 50 provide 58% sensitivity and 96% specifi-
city. Additionally, index values of IgG anti-Dsg1 autoantibodies
above 10 were associated with a 100% observed sensitivity and
specificity (see Figure S5). The cutoff of 50 for IgM and 10 for IgG
were used throughout these studies. The percentages of positive
samples for IgM and IgG anti-Dsg1 autoantibodies were determined
for each group tested. The distribution of individual samples in each
group was also expressed as box plots (see below).
For calcium effect study, 5mM EDTA was added to Tris-buffered
saline without Ca2þ , and the buffer was used in the ELISA.
Reproducibility of the Dsg1 ELISA for IgM and IgG was performed
by two independent investigators testing a set of 48 sera selected and
coded by a third individual. The results demonstrated a nearly
perfect linear relationship with correlation coefficient of 0.977
(Po0.001). Readings by one reader tended to be greater in
magnitude by about 11%. Using either reader’s results would
produce nearly identical results for the hypotheses of interest in this
report.
To test for competitive inhibition of IgG and IgM anti-Dsg1
autoantibodies for the binding sites of immobilized Dsg1 on
the ELISA microtiter wells, the following experiments were
performed: a set of FS sera with a high-titer IgG anti-Dgs1 and low
IgM anti-Dsg1 were selected and were tested at 1:100, 1:200, 1:400,
and 1:800 dilutions. Index values were determined for each dilution.
Additionally, microtiter wells coated with Dsg1 were preincubated
with a high-titer IgG anti-Dsg1 serum at a dilution of 1:100, then
tested using a 1:100 dilution of high IgM anti-Dsg1 sera. The
remainder of the ELISA procedure was carried out as described
above.
Indirect IF and immunoprecipitation/immunoblotting assays
Indirect IF techniques were carried out as reported previously
(Rock et al., 1989). Briefly, human skin and monkey esophagus
cryosections were incubated with a 1:20 and 1:40 dilutions of test
sera. Positive sera were titrated to the end point. Human IgG
antibodies were detected using FITC-labelled goat anti-human
IgG serum (MP Biomedicals LLC, Solon, OH) and human IgM
autoantibodies with murine monoclonal anti-human IgM antibodies
(Southern Biotech, Birmingham, AL) and FITC-labelled sheep anti-
mouse IgG (MP Biomedicals LLC).
Immunoprecipitation followed by immunoblotting was carried
out as described previously (Ding et al., 1999; Li et al., 2003).
Briefly, the sera from patients and controls were incubated with
recombinant Dsg1 at 41C overnight. IgM anti-Dsg1 autoantibodies
were immunoprecipitated using goat anti-human IgM (U-chain
specific)-Agarose coated beads (Sigma-Aldridge, St Louis, MO). IgG
anti-Dsg1 autoantibodies were immunoprecipitated using recombi-
nant Staph protein G-coated Sepharose 4B beads (Invitrogen,
Carlsbad, CA). Immunoprecipitated Dsg1 was extracted with 1%
SDS, run on 10% SDS–PAGE and transferred onto nitrocellulose
membranes (Bio-Rad, Hercules, CA), and finally probed with a
1:2000 dilution of horseradish peroxidase-labeled monoclonal anti-
HIS antibodies (Qiagen, Valencia, CA). Specific bands were
demonstrated by chemiluminescense (GE Healthcare Limited,
Piscataway, NJ).
Statistical analysis
The distribution of index values of each sample for each group was
determined and a box plot constructed. The box plot of each group
was analyzed for significance and trends. Differences among groups
were analyzed using one-way analysis of variance. Further analyses
used non-parametric one-way analysis (Mann–Whitney and VDW)
and Winsorization. Analyses were carried out in SAS, version 9.1,
and R, version 2.2. Linear regression was used for estimation of IgM
and IgG trends with age. For paired data, as in Figure 4, the pair t-test
was used. The Supplementary Material includes box plots of IgM and
IgG in the different groups.
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Figure S1. Box plot representation of IgM and IgG anti-Dsg1 reactivity of sera
from patients with FS and PF.
Figure S2. Box plot representation of IgM and IgG anti-Dsg1 reactivity of sera
from healthy control individuals from rural and urban sites.
Figure S3. Scatter representation of IgM and IgG anti-Dsg1 reactivity of sera
from healthy donors age 5–20.
Figure S4. Receiver operator characteristic curve of IgM anti-Dsg1 index
values of FS sera (N¼ 31) and NHS (N¼55) and cut point determination of
sensitivity and specificity.
Figure S5. Receiver operator characteristic curve of IgG anti-Dsg1 index
values of Japanese PF sera (N¼20) and NHS (N¼ 50) and cut point
determination of sensitivity and specificity.
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